Health Ministry to Roll Out Free HPV Vaccination for 14-Year-Old Girls

**Overview** In late February 2026, the Union Health Ministry announced preparations to roll out a comprehensive, free Human Papillomavirus (HPV) vaccination program actively targeting 14-year-old girls nationwide, marking a decisive public health intervention to eliminate cervical cancer in India. **Key Highlights** • The vaccination drive will be systematically integrated into the Universal Immunization Programme (UIP) across all states. • The initiative specifically targets girls aged 14, providing them with critical protection before potential virus exposure. • India currently accounts for nearly a quarter of the world's cervical cancer deaths, making this a high-priority demographic intervention. • The government will predominantly utilize the indigenous quadrivalent vaccine 'CERVAVAC', developed by the Serum Institute of India. • Utilizing locally manufactured vaccines drastically brings down the cost per dose compared to imported alternatives. • The campaign will involve massive school-based inoculation drives and community health center outreach. • It perfectly aligns with the World Health Organization's (WHO) global strategy to accelerate the elimination of cervical cancer. **Key Developments / Drivers** Cervical cancer is the second most common cancer among women in India. The primary driver behind this initiative is the successful indigenization of the HPV vaccine, which transformed an expensive, imported medical commodity into an affordable, mass-deployable public health tool. The strategic pivot towards preventive oncology emphasizes early inoculation, significantly reducing the massive future economic and social burdens associated with advanced cancer treatments. **Strategic Importance** This topic is critically relevant for UPSC GS Paper 2 (Health, Social Justice) and GS Paper 3 (Biotechnology, Indigenization of Technology). The mass rollout of CERVAVAC serves as a monumental testament to India's 'Make in India' success in the biopharmaceutical sector. It strongly reflects the government's commitment to gender-equitable healthcare access, empowering women and directly improving maternal and holistic health metrics. **Future Outlook** The successful nationwide execution of the HPV vaccination plan is expected to dramatically reduce the incidence of cervical cancer in India within the next decade. As the program scales, continuous public awareness campaigns will eradicate vaccine hesitancy, eventually setting a strong precedent for integrating other advanced preventive genomics and biotechnology solutions into India's primary healthcare architecture.